Journal of Jilin University(Medicine Edition) ›› 2023, Vol. 49 ›› Issue (4): 975-984.doi: 10.13481/j.1671-587X.20230419
• Research in basic medicine • Previous Articles Next Articles
Shan LIU1,Zhaodong XING2,Ping HUANG1(
)
Received:2022-08-22
Online:2023-07-28
Published:2023-07-26
Contact:
Ping HUANG
E-mail:13876380118@163.com
CLC Number:
Shan LIU,Zhaodong XING,Ping HUANG. Effect of expression of miR-17-5p in exosomes derived from colorectal cancer cells on chemosensitivity of colorectal cancer cells and its mechanism[J].Journal of Jilin University(Medicine Edition), 2023, 49(4): 975-984.
| 1 | BAIDOUN F, ELSHIWY K, ELKERAIE Y, et al. Colorectal cancer epidemiology: recent trends and impact on outcomes[J]. Curr Drug Targets,2021,22(9): 998-1009. |
| 2 | BILLER L H, SCHRAG D. Diagnosis and treatment of metastatic colorectal cancer: a review[J]. JAMA, 2021, 325(7): 669-685. |
| 3 | FAN A H, WANG B D, WANG X, et al. Immunotherapy in colorectal cancer: current achievements and future perspective[J]. Int J Biol Sci, 2021, 17(14): 3837-3849. |
| 4 | BLONDY S, DAVID V, VERDIER M, et al. 5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes[J]. Cancer Sci, 2020, 111(9): 3142-3154. |
| 5 | TIAN X Y, SHEN H, LI Z Y, et al. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment[J].J Hematol Oncol,2019,12(1):84. |
| 6 | COSTA V RDA, ARALDI R P, VIGERELLI H,et al. Exosomes in the tumor microenvironment: from biology to clinical applications[J]. Cells, 2021, 10(10): 2617. |
| 7 | LI I, NABET B Y. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance[J]. Mol Cancer, 2019, 18(1): 32. |
| 8 | ZHANG J, LI S, LI L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function[J]. Genomics Proteomics Bioinformatics,2015,13(1):17-24. |
| 9 | YU W F, WANG J, LI C, et al. miR-17-5p promotes the invasion and migration of colorectal cancer by regulating HSPB2[J]. J Cancer, 2022, 13(3): 918-931. |
| 10 | BACH D H, HONG J Y, PARK H J, et al. The role of exosomes and miRNAs in drug-resistance of cancer cells[J]. Int J Cancer, 2017, 141(2): 220-230. |
| 11 | TRAN N. Cancer exosomes as miRNA factories[J]. Trends Cancer, 2016, 2(7): 329-331. |
| 12 | WANG S H, XU M Q, LI X X, et al. Exosomes released by hepatocarcinoma cells endow adipocytes with tumor-promoting properties[J]. J Hematol Oncol, 2018, 11(1): 82. |
| 13 | SUN W, REN Y, LU Z M, et al. The potential roles of exosomes in pancreatic cancer initiation and metastasis[J]. Mol Cancer, 2020, 19(1): 135. |
| 14 | LUNAVAT T R, CHENG L, EINARSDOTTIR B O, et al. BRAFV600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells[J]. Proc Natl Acad Sci U S A, 2017, 114(29): E5930-E5939. |
| 15 | YANG Q X, ZHAO S R, SHI Z D, et al. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling[J]. J Exp Clin Cancer Res, 2021, 40(1): 120. |
| 16 | LIANG G F, ZHU Y L, ALI D J, et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer[J]. J Nanobiotechnology, 2020, 18(1): 10. |
| 17 | LIU T, ZHANG X, DU L T, et al. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer[J]. Mol Cancer, 2019, 18(1): 43. |
| 18 | ULUKAYA E, KARAKAS D, DIMAS K. Tumor chemosensitivity assays are helpful for personalized cytotoxic treatments in cancer patients[J]. Medicina, 2021, 57(6): 636. |
| 19 | SOGHLI N, FERNS G A, SADEGHSOLTANI F,et al.microRNAs and osteosarcoma: potential targets for inhibiting metastasis and increasing chemosensitivity[J]. Biochem Pharmacol, 2022, 201: 115094. |
| 20 | 尹春金, 权海燕, 朴 颖, 等. 自噬在酒精性肝病发生发展中的作用研究进展[J]. 延边大学医学学报,2022,45(1):63-67. |
| 21 | WANG X, ZHOU Y, DING K. Roles of exosomes in cancer chemotherapy resistance, progression, metastasis and immunity, and their clinical applications (Review)[J]. Int J Oncol, 2021, 59(1): 44. |
| 22 | WANG S, FENG W, WANG W L, et al. Girdin knockdown increases gemcitabine chemosensitivity to pancreatic cancer by modulating autophagy[J]. Front Oncol, 2021, 11: 618764. |
| 23 | NINFOLE E, PINTO C, BENEDETTI A, et al. Role of autophagy in cholangiocarcinoma: Pathophysiology and implications for therapy[J]. World J Clin Cases, 2021, 9(22): 6234-6243. |
|